Literature DB >> 11870015

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Nobuyuki Okamura1, Hiroyuki Arai, Masahiro Maruyama, Makoto Higuchi, Toshifumi Matsui, Haruko Tanji, Takashi Seki, Hisao Hirai, Hiroshi Chiba, Masatoshi Itoh, Hidetada Sasaki.   

Abstract

OBJECTIVE: The aim of this study was to establish an objective and reliable index to predict the development of Alzheimer's disease in a large pool of elderly patients with mild cognitive impairment.
METHOD: Twenty-three patients with probable Alzheimer's disease, 22 patients with mild cognitive impairment who eventually developed Alzheimer's disease, eight patients with mild cognitive impairment who did not develop dementia, and 19 cognitively normal subjects were included in the study. The authors constructed a new diagnostic index, the CSF-CBF index, based on CSF tau levels divided by regional cerebral blood flow (CBF) in the posterior cingulate cortex.
RESULTS: Receiver operating characteristic analysis showed that applying a cutoff value for the CSF-CBF index of 296.0 achieved a sensitivity of 88.5% and a specificity of 90.0% in discriminating mild cognitive impairment that progressed to Alzheimer's disease from mild cognitive impairment that did not progress to Alzheimer's disease.
CONCLUSIONS: The CSF-CBF index is useful in predicting Alzheimer's disease in subjects with mild cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870015     DOI: 10.1176/appi.ajp.159.3.474

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

Review 1.  Multiple sclerosis and Alzheimer disease through the looking glass of MR imaging.

Authors:  Giovanni B Frisoni; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

2.  Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis.

Authors:  Barbara Borroni; Daniela Perani; Marcella Broli; Francesca Colciaghi; Valentina Garibotto; Barbara Paghera; Chiara Agosti; Raffaele Giubbini; Monica Di Luca; Alessandro Padovani
Journal:  J Neurol       Date:  2005-06-24       Impact factor: 4.849

3.  Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.

Authors:  Anna Caroli; Cristina Testa; Cristina Geroldi; Flavio Nobili; Ugo P Guerra; Matteo Bonetti; Giovanni B Frisoni
Journal:  J Neurol       Date:  2007-03-20       Impact factor: 4.849

4.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

5.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

6.  [Lithium intoxication mimics Alzheimer's disease in PET and clinical findings].

Authors:  Peter Tonn; Peter Bartenstein; Norbert Dahmen
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

Review 7.  Update on mild cognitive impairment.

Authors:  David A Bennett
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

8.  Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.

Authors:  Lisa Mosconi; Susan De Santi; Miroslaw Brys; Wai H Tsui; Elizabeth Pirraglia; Lidia Glodzik-Sobanska; Kenneth E Rich; Remigius Switalski; Pankaj D Mehta; Domenico Pratico; Ray Zinkowski; Kay Blennow; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2007-08-27       Impact factor: 13.382

10.  Effects of partial volume correction on discrimination between very early Alzheimer's dementia and controls using brain perfusion SPECT.

Authors:  Hidekazu Kanetaka; Hiroshi Matsuda; Takashi Asada; Takashi Ohnishi; Fumio Yamashita; Etsuko Imabayashi; Fumiko Tanaka; Seigo Nakano; Masaru Takasaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.